SW
NVO

SteelPeak Wealth’s Novo Nordisk NVO Stock Holding History

SteelPeak Wealth’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Hold
0
– -$69.4K – 635
2025
Q1 		– Hold
0
– – – 536

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

SteelPeak Wealth's NVO Position: Q2 2026 in Review

SteelPeak Wealth reduced its Novo Nordisk (NVO) stake by 4.9% in Q2 2026, selling an estimated $11.9K and leaving 5,376 shares worth $258K. The position accounts for 0.01% of the portfolio, ranked #565.

SteelPeak Wealth first reported a position in NVO in Q4 2021 and has held it in 18 quarters since. The position peaked at $671K in Q4 2024. 583 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • SteelPeak Wealth held 5,376 shares of Novo Nordisk worth $258K as of Q2 2026.
  • SteelPeak Wealth sold 277 Novo Nordisk shares in Q2 2026, an estimated $11.9K.
  • Novo Nordisk made up 0.01% of SteelPeak Wealth's portfolio in Q2 2026, its #565 holding.
  • SteelPeak Wealth first reported a position in Novo Nordisk in Q4 2021 and has held it in 18 quarters since.
  • SteelPeak Wealth's Novo Nordisk position peaked at $671K in Q4 2024.
  • 583 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on SteelPeak Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.